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I
amYoncaA.Akova,MD-fromtheDepartmentof Ophthalmology,BayindirKavaklidereHospital,Turkey.I wrotethislettertoevaluatetheefficacyof0.05%topical cyclosporineA(CsA)eyedrops(RestasisAllergan,Irvine, USA)insymptomaticpatientswithrecurrentsubepithelial infiltrates(SEIs)duetoadenoviralkeratoconjunctivitis followingsteroideyedropstaperingordiscontinuation. Duringthenaturalcourseofepidemickeratoconjunctivitis, somepatientsdevelopSEIsandthosemaypersistforseveral monthstoyearsandcausevisualimpairment,halosandglare inasubsetofpatients [1] .Histopathologicstudiessuggestthat SEIs arecomposedoflymphocytes,histiocytesand fibroblastsandarethoughttooccurasaresultofdelayed immuneresponsetoviralantigensinthecornealstroma [2] . Thishypothesisissupportedbygoodresponsetotopical steroidtherapy,howeverundesirablecomplicationslike cataract,glaucomaandmicrobialsuperinfectionsmayoccur withprolongeduseoftopicalsteroidsandalsorelapsemay occuraftertaperingordiscontinuationofsteroids [1] .Recently, fewreportsthathaveshowntheefficacyoftopicalCsAin variousconcentrationsonSEIshavebeenpublished [3] [4] [5] [6] [7] . [1, 3] . Recently,theefficacyoftopicalCsAindifferent concentrationsforthetreatmentofSEIshasbeenreportedin anumberofstudies [3, [5] [6] [7] .Thelargestseriesofpatientsreceived topicalCsAforthetreatmentofSEIswasreportedbya Germangroup [6] .Theytreated70eyesof48patientswith2% CsAfourtimesadayatthebeginningandreducedthe frequencyof2%CsAdependingonresolutionoftheSEIs. Fortyeyesrespondedwell,16eyesshowednochangeand thetherapywasstoppedin4eyesbecauseofsevere intoleranceto2%CsAtherapy.Completecurewasachieved withoutrecurrencein10eyes.Levinger [7] treated9 steroidresistantorsteroidresponderpatientswith1%CsA eyedropstwicedaily.Sixty-sixpercentofpatientsshowed clinicalimprovement,whilethirty-fourpercentremained stable [7] .Tothebestofourknowledge,therehasbeenonly onereportregardingtheefficacyofcommerciallyavailable topicalCsA0.05%,whichisalowerconcentrationthanthe preparationspreviouslyusedforthisindicationinthe literature [5] .Thisgroupusedtopical0.05%CsAin16patients (22eyes)withSEIswhohadbeenpreviouslytreatedwith topicalsteroidswithoutanyimprovementorhadtostop topicalsteroidssecondarytointraocularpressureelevation. 0.05%CsAwasadministeredfourtimesforthefirst15d,and then2timesadayfornext15d.Eighteeneyes(81.9%) showedclinicalimprovementwhileSEIsdidnotcompletely disappearin4eyes [5] . 
